Remove Genetic Analysis Remove Medicine Remove Scientist
article thumbnail

Minimal SARS-CoV-2 diversity suggests a global vaccine is feasible

Scienmag

Genetic analysis of sequences from more than 27,000 individuals infected with the coronavirus that causes COVID-19 reveals that the virus has mutated minimally since December 2019, suggesting one vaccine would be sufficient to combat global infections.

article thumbnail

AI test could predict best cancer therapies for patients

pharmaphorum

The AI can product response of a tumour to treatment with drugs delivered as single agents or in combination, according to the scientists, who have published their findings in the journal Molecular Cancer Therapeutics.

Protein 67
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Immunotherapies could target aggressive pancreatic cancer, research indicates

The Pharma Data

Scientists have discovered that hard-to-treat pancreatic cancer hijacks a key immune system response. We found that there is a complex interplay between cancer and immune cells in the most aggressive type of pancreatic neuroendocrine tumours, which suggests immunotherapy could work for patients with this form of the disease.

article thumbnail

Beam makes USD 120M bet; GRAIL and Quest announce the collaboration; Brain organoids mimic infant’s brains; Improvement in T cells to kill cancer

Delveinsight

Beam Therapeutics has taken over a startup whose technology could proffer the biotech’s genetic medicines to more tissues in the body, widening the potential to approach more diseases. Cambridge, Massachusetts-based Beam aims to make more precise edits with genetic medicines, which employ base-editing.

DNA 52